324 related articles for article (PubMed ID: 27154483)
1. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.
Ensor J; Riley RD; Moore D; Snell KI; Bayliss S; Fitzmaurice D
BMJ Open; 2016 May; 6(5):e011190. PubMed ID: 27154483
[TBL] [Abstract][Full Text] [Related]
2. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
[TBL] [Abstract][Full Text] [Related]
3. Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE.
Ensor J; Riley RD; Moore D; Bayliss S; Jowett S; Fitzmaurice DA
Syst Rev; 2013 Oct; 2():91. PubMed ID: 24089702
[TBL] [Abstract][Full Text] [Related]
4. Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
de Winter MA; van Es N; Büller HR; Visseren FLJ; Nijkeuter M
Thromb Res; 2021 Mar; 199():85-96. PubMed ID: 33485094
[TBL] [Abstract][Full Text] [Related]
5. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
6. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
7. Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
Timp JF; Braekkan SK; Lijfering WM; van Hylckama Vlieg A; Hansen JB; Rosendaal FR; le Cessie S; Cannegieter SC
PLoS Med; 2019 Oct; 16(10):e1002883. PubMed ID: 31603898
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trial.
Raj L; Presles E; Le Mao R; Robin P; Sanchez O; Pernod G; Bertoletti L; Jego P; Lemarié CA; Leven F; Hoffmann C; Planquette B; Le Roux PY; Slaun PY; Nonent M; Girard P; Lacut K; Mélac S; Guégan M; Mismetti P; Laporte S; Meyer G; Leroyer C; Tromeur C; Couturaud F;
Am J Med; 2020 Aug; 133(8):e406-e421. PubMed ID: 32333853
[TBL] [Abstract][Full Text] [Related]
9. Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score.
Marín-Romero S; Elías-Hernández T; Asensio-Cruz MI; Ortega-Rivera R; Morillo-Guerrero R; Toral J; Montero E; Sánchez V; Arellano E; Sánchez-Díaz JM; Real-Domínguez M; Otero-Candelera R; Jara-Palomares L
Arch Bronconeumol (Engl Ed); 2019 Dec; 55(12):619-626. PubMed ID: 31130245
[TBL] [Abstract][Full Text] [Related]
10. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.
Rodger MA; Le Gal G; Anderson DR; Schmidt J; Pernod G; Kahn SR; Righini M; Mismetti P; Kearon C; Meyer G; Elias A; Ramsay T; Ortel TL; Huisman MV; Kovacs MJ;
BMJ; 2017 Mar; 356():j1065. PubMed ID: 28314711
[No Abstract] [Full Text] [Related]
11. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
12. Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data.
Marcucci M; Iorio A; Douketis JD; Eichinger S; Tosetto A; Baglin T; Cushman M; Palareti G; Poli D; Tait RC; Kyrle PA
J Thromb Haemost; 2015 May; 13(5):775-81. PubMed ID: 25660555
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Schulman S; Couturaud F; Prandoni P; Eichinger S; Becattini C; Agnelli G; Büller HR; Brighton TA; Palareti G; Pinede L; Sabri E; Hutton B; Wells GA; Rodger MA;
BMJ Open; 2017 Sep; 7(9):16950. PubMed ID: 28939565
[TBL] [Abstract][Full Text] [Related]
14. New Trends in Anticoagulation Therapy.
Smith M; Wakam G; Wakefield T; Obi A
Surg Clin North Am; 2018 Apr; 98(2):219-238. PubMed ID: 29502768
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
[TBL] [Abstract][Full Text] [Related]
16. Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients.
Betancourt MT; Rodger MA
Acta Chir Belg; 2007; 107(6):636-40. PubMed ID: 18274176
[TBL] [Abstract][Full Text] [Related]
17. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer?
Rodger MA; Le Gal G; Langlois NJ; Gin B; Mallick R; Giulivi A; Freedman M; Kovacs MJ;
Thromb Res; 2018 Sep; 169():82-86. PubMed ID: 30031290
[TBL] [Abstract][Full Text] [Related]
18. Predicting recurrence after unprovoked venous thromboembolism: prospective validation of the updated Vienna Prediction Model.
Tritschler T; Méan M; Limacher A; Rodondi N; Aujesky D
Blood; 2015 Oct; 126(16):1949-51. PubMed ID: 26341256
[TBL] [Abstract][Full Text] [Related]
19. Bleeding risk in patients with unprovoked venous thromboembolism: A critical appraisal of clinical prediction scores.
van Es N; Wells PS; Carrier M
Thromb Res; 2017 Apr; 152():52-60. PubMed ID: 28237891
[TBL] [Abstract][Full Text] [Related]
20. Extended therapy for primary and secondary prevention of venous thromboembolism.
Conway SE; Marcy TR
J Pharm Pract; 2010 Aug; 23(4):313-23. PubMed ID: 21507831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
